OncoSec
-
Yardley-Based Jubilant Therapeutics Appoints Industry Veteran as New CEO
Jubilant Therapeutics, a Yardley-based biopharmaceutical company focused on cancer and autoimmune disease treatments, has named Daniel J. O’Connor to be…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
